triflupromazine has been researched along with Substance Withdrawal Syndrome in 2 studies
Triflupromazine: A phenothiazine used as an antipsychotic agent and as an antiemetic.
triflupromazine : A member of the class of phenothiazines that is 10H-phenothiazine having a trifluoromethyl subsitituent at the 2-position and a 3-(dimethylamino)propyl group at the N-10 position.
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, M | 1 |
| Chen, CC | 1 |
| Akiyama, K | 1 |
| Otsuki, S | 1 |
| Crane, GE | 1 |
| Naranjo, ER | 1 |
1 trial available for triflupromazine and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Motor disorders induced by neuroleptics: a proposed new classification.
Topics: Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Dystonia Musculorum Deformans; Factor A | 1971 |
1 other study available for triflupromazine and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis.
Topics: Adult; Delusions; Hallucinations; Haloperidol; Humans; Male; Methamphetamine; Paranoid Disorders; Ps | 1983 |